Monoclonal antibody to the haemagglutinin-neuraminidase or the fusion glycoprotein of Newcastle disease virus blocked virus penetration which otherwise occurred within 90 s of the temperature being increased from 4 °C to 37 °C. These antibodies regularly immunoselected variant plaques only when incorporated into the agarose overlay. Variant viruses then formed plaques whereas the growth of non-neutralized normal virus was suppressed.
Monoclonal antibodies (MCA) have been used to analyse the mechanisms of virus neutralization and to immunoselect variants (see Oxford, 1982) . The neutralization of Newcastle disease virus (NDV) by MCA 445 to the haemagglutinin-neuraminidase (HN-2) epitope and MCA 481 to fusion (F) protein was independent of haemagglutination inhibition (HI) whereas a weaker neutralization, which could be potentiated by complement, was associated with HI by MCAs 14, 32 and 86 to the HN-1 epitope (Russell et al., 1983b) . In the present paper MCAs 14, 445 and 481 have been used to investigate virus penetration by the procedure of Massey & Schochetman (1981) who showed that preadsorbed mouse mammary tumour virus (MMTV) resisted neutralization by MCA. Preadsorbed NDV, in contrast, was neutralized and the speed at which NDV would have otherwise penetrated cells at 37 °C was investigated.
Whereas the infectivity of MMTV had been measured by focus formation after 7 to 10 days, the infectivity of NDV (Ulster) was measurable by indirect immunoperoxidase (liP) staining of the initially infected cells after 1 day (Russell et al., 1983a) . This liP assay is possible because NDV (Ulster) cannot spread from initially infected Madin-Darby bovine kidney (MDBK) cells by cell fusion or by the release of infectious virus (Alexander et al., 1973; Nagai et al., 1976) .
In the second part of this paper MCA 445 and 481 were used to determine whether NDV had the same high mutational frequencies as other RNA viruses (see Holland et al., 1982) . Antibody in the overlay was necessary to immunoselect variant plaques regularly, and to what extent it complicated any estimation of the mutant content in the stock is discussed.
The drop in infectivity with various dilutions of MCA as heat-inactivated ascites fluid was first assayed by the micro-neutralization test of Russell et al. (1983 a) . In brief, 50 p.1 vol. of virus and MCA were reacted for 2 h at 37 °C and then adsorbed to microwells of MDBK cells overnight. Infected cells were then counted by liP using a mixture of MCA to HN-1 (MCA 32), F (MCA 481) and nucleoprotein (MCA 479) . MCA 688 to the viral polymerase did not neutralize. MCA 14 to HN-1 caused a 25-fold drop in the dilution range of 10-1.3 to 10 -4 as if it was in antibody excess over this range of dilutions but was unable to neutralize completely ( (Russell et al., 1983a) .
whereas rabbit antiserum to NDV and MCAs 14, 445 and 481 each neutralized at least 80~ of the infectivity (Table 1 ). The rabbit antiserum to NDV completely neutralized the penetrating virus and the MCAs to F, HN-2 and HN-1 blocked penetration with decreasing efficiency (Table 1) . In a second experiment the temperature of the preadsorbed virus was shifted to 37 °C for various time intervals before adding antibody at 4 °C for 2 h prior to the usual overnight incubation at 37 °C. About half the virus escaped neutralization when the temperature was shifted to 37 °C for 30 s before adding antibody, and escape was complete by 90 s (Table 1) . NDV (Ulster) could therefore penetrate MDBK cells within 90s at 37 °C. This rapid penetration of NDV (Ulster) corresponds to the time taken for fowl plague virus to penetrate Madin-Darby canine kidney cells (Matlin et al., 1981) but is faster than the 1 h taken by NDV (Australia = Victoria) to penetrate chick embryo cells and escape neutralization (Smith & Hightower, 1982) .
For the immunoselection of variant plaques an over-neutralizing amount of antibody is necessary. With MCA 445 and 481 this could not be achieved because neither gave a plateau level of neutralization (Fig. 1) . Similar drops in infectivity with a 1 in 50 dilution of MCA were recorded by plaque reduction and IIP: 102 for MCA 445 and l0 s for MCA 481 (Table 2) . Heattreated MCA 14 was not used to select variants because it repeatedly reduced plaque formation by less than 101 (Table 2) . 1" Apparent value (see text).
Plaque reduction was enhanced 100-fold with MCA 445 and threefold with MCA 481 when the antibodies remained at a dilution of 1 in 500 in the agarose overlay. This was specific because it occurred in virus control plates of NDV (Ulster) but not in virus control plates of NDV (La Sota) or Sendai virus when MCA was added 1 day or 1 h after adsorption; La Sota and Sendai virus also require trypsin for plaquing but do not bind to MCA 445 or 481. Foci of 10 to 40 infected cells could be seen by liP when MCA 445 as compared to MCA 481 was in the overlay. MCA 445 was therefore able to neutralize plaque formation without completely neutralizing either input virus or the virus replicated by MDBK cells in the Petri plate.
MCA 445 and 481 each reduced plaque formation by at least 104 when added to the overlay. This corresponded to the critical neutralization index (NI) for the immunoselection of rabies virus variants in a similar system (Wiktor & Koprowski, 1980) . For NDV (Ulster) such neutralization also ensured that variants were immunoselected because every surviving plaque contained variant virus which escaped binding and neutralization by the immunoselecting MCA but was neutralized via the other two epitopes (Table 2) . If antibody was omitted from the overlay all plaques which survived MCA 445 contained normal virus as did three of the five plaques which survived MCA 481 ( Table 2 ). The regular immunoselection of variants by a subneutralizing amount of MCA therefore required antibody in the overlay.
The 36 variants were all genetically stable after two plaque clonings followed by amplification in eggs. They were recent mutants because the stock of virus used throughout this work had been plaque-cloned three times and then an inoculum of 103 p.f.u, derived from one tertiary plaque was amplified to 101°2 p.f.u, by growth in an individual egg. The content of mutants that had an altered F epitope (defined by heat-treated MCA 481) was therefore 103.7 p.f.u./ml in a stock containing 109.2 p.f.u./ml ( Table 2 ). The mutational rate of the F epitope could not be calculated, however, because the virus stock had been through more than one replication cycle during amplification from 1 p.f.u, to 10 l° p.f.u.
The content of mutants with an altered HN-2 epitope (defined by heat-treated MCA 445) could not be assessed because virus replication during focus formation under the antibody overlay may have seeded variant p.f.u, which were additional to those in the original virus stock. In the experiments with MCA in the overlay any measurement of NI by plaque reduction would also have been an overestimate because virus, which had not been neutralized during the 2 h reaction time, would not have plaqued unless it was a mutant or had generated a mutant during focus formation. Smith & Hightower (1982) reported that H N function as welt as F function affected the rate of penetration of NDV which had been preadsorbed at 4 °C. This is corroborated by the present work which uses MCA instead of temperature-sensitive mutants and revertants. If the most complete method of neutralizing NDV (Ulster) involves a block of the very rapid penetration phase this would explain why MCA 481 is a better neutralizer than MCA 445 or MCA 14 because steric hindrance of penetration by MCA would be more direct via F compared to HN. This work was supported by a grant from The Wellcome Trust.
